CGEM Archived Articles
Cullinan Therapeutics (CGEM): Building a Diversified Pipeline Across Autoimmune Diseases and Oncology
Published on November 17, 2024
Cullinan Therapeutics, Inc. (NASDAQ:CGEM): A Promising Oncology and Autoimmune Pipeline Backed by Robust Financials
Published on September 24, 2024